@j44tp: منوعات لفهد معيان #فهد_معيان #الواقع #fyp #foryou #explore . . . @فهد معيّان @ناصر الغامدي

أكشن الواقع🌐

Open In TikTok:

Region: SA

Monday 03 August 2026 16:12:38 GMT

100070

2854

58

147

Music

Download

No Watermark .mp4 (1.24MB) No Watermark(HD) .mp4 (1.7MB) Watermark .mp4 (2.22MB) Music .mp3

Comments

ابواصيل علي الثبيتي :

كفو فهد معيان👍👍👍

2026-08-04 07:51:18

2

الدرة💎 :

كان سعود معه ويهديه ويسنده في غضبه 🥺الله يرحمه😭😭😭

2026-08-04 12:50:39

7

. :

انشششهدد ان مو متقبله البرنامج لان مو موجود الله يرحمه🥲

2026-08-03 20:42:48

47

🌊 :

يارب يرجع المكانه اللي محد يقدر يجمله الا هو🥺🥺🥺😢

2026-08-03 23:46:45

10

❣️ :

كنت انتظر البرنامج هذا عقب م توفى سعود الله يرحمه و غاب فهد معيان والله م اتابعهم لانهم سامجين البرنامج من بعدهم و لا بريال 💔

2026-08-04 03:36:47

0

فتو💕 :

الله يرحم لابوعبدالله ويغفرله

2026-08-03 23:44:46

5

عبدالله 🎭 :

ساطي ابوقحط😂👌

2026-08-04 16:25:11

3

` :

كفوووووو انشهد، واحسن جلد عصام بذاك الوقت

2026-08-04 06:44:19

1

٠٠ :

اي والله لن يملئ كرسيكم احد 😭😭😭😭

2026-08-04 04:46:25

1

… :

قال وصدق الله يرحم سعود ويصبرك ي فهد

2026-08-04 01:02:39

1

lavender :

ياخي فهد ❤️

2026-08-03 23:55:12

1

Nor :

اي والله سعودالله يرحمه ويجعله في الجنه كمقدم لن يملأ مكانه احد اتضحت في النقد الجديد

2026-08-04 00:25:12

1

أم منو :

انا اشهد انه صادق هو لحاله قناة صراحة الله يرحم سعود

2026-08-04 02:21:02

1

n :

فعععلا والله

2026-08-04 13:46:57

0

عابد"𝐀𝐳𝐃 👑715 :

قادح حي

2026-08-04 12:56:14

0

ن :

حرام ي ان النقد حالياً فاشل مافيه من يحشر المتسابقين الحين يسكتونهم المتسابقين

2026-08-04 00:20:48

1

Jojo :

صدقت 💔💔💔💔

2026-08-03 18:54:01

1

T :

الله يرحمك ياسعود ويدخلك فسيح جناته بلا حساب ولا عذاب وجميع المسلمين والمسلمات والمؤمنين والمؤمنات الأحياء منهم والاموات

2026-08-03 21:07:55

8

🪐 :

اكثر شي ليته يرجع

2026-08-04 00:15:08

1

سلمان السمران🥀 :

فعلاً

2026-08-04 11:40:30

0

ألمهره :

كفوا يافهد ميجؤ بعدك احد انت وسعود لله يرحمه

2026-08-04 17:13:34

0

G G 🇸🇦 :

والله انه قادح وقول وفعل ان الفقره بدونه مستحيل تمشي ونتقبلها الا بفهد معيان

2026-08-04 17:03:09

0

G G 🇸🇦 :

والله ياهو فقيده يارب يرجع للنقدددد

2026-08-04 17:02:35

0

كاريزما3 :

💔💔💔🥺🥺 آية والله مكانكم خالي

2026-08-03 18:53:46

1

To see more videos from user @j44tp, please go to the Tikwm homepage.

Other Videos

¿Porque lo hicimos? Síguenos en @ViVentos #tacna_peru #depresion #porquelohiciste #ladepresionesreal #peru

¿Porque lo hicimos? Síguenos en @ViVentos #tacna_peru #depresion #porquelohiciste #ladepresionesreal #peru

🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

#emission

Musafir Musafir Jana Nahi 🥹❤️‍🩹🎧🤌🏻 . . . #foryoupage #fyp #goviral #sadsong #zishuesticx

Musafir Musafir Jana Nahi 🥹❤️‍🩹🎧🤌🏻 . . . #foryoupage #fyp #goviral #sadsong #zishuesticx

About

Robot
API

Legal

Privacy Policy